Pharmacoepidemiology, Fifth Edition

Pharmacoepidemiology, Fifth Edition

Editor(s): Brian L. Strom, Stephen E. Kimmel, Sean Hennessy

Published Online: 3 JAN 2012

Print ISBN: 9780470654750

Online ISBN: 9781119959946

DOI: 10.1002/9781119959946

About this Book

Now in its fifth edition, Pharmacoepidemiology defines the discipline and provides the most comprehensive guidance of any book on the topic. Written by world renowned experts in the field, this valuable text surveys the research designs and sources of data available for pharmacoepidemiologic research, and provides descriptions of various automated data systems, along with the advantages and disadvantages of each.  Incorporating perspectives from academia, industry and regulatory agencies, this book provides detailed insights into all aspects of pharmacoepidemiology.

Table of contents

    1. You have free access to this content
  1. Part I: Introduction

  2. Part II: The Role of Pharmacoepidemiology in Different Sectors

    1. Chapter 7

      The Role of Pharmacoepidemiology in Industry (pages 84–106)

      Jingping Mo, Nicolle M. Gatto, Rachel E. Sobel and Robert F. Reynolds

  3. Part III: Sources of Data for Pharmacoepidemiologic Studies - Section A: Spontaneous Reporting

  4. Part III: Sources of Data for Pharmacoepidemiologic Studies - Section B: Automated Data Systems

    1. Chapter 12

      Health Maintenance Organizations/Health Plans (pages 163–188)

      Susan E. Andrade, Marsha A. Raebel, Denise Boudreau, Robert L. Davis, Katherine Haffenreffer, Pamala A. Pawloski, Sengwee Toh and Richard Platt

    2. Chapter 14

      US Government Claims Databases (pages 209–223)

      Sean Hennessy, Cristin Palumbo Freeman and Francesca Cunningham

    3. Chapter 15

      Medical Record Databases (pages 224–243)

      Alexis Ogdie, Sinéad M. Langan, John Parkinson, Hassy Dattani, Karel Kostev and Joel M. Gelfand

    4. Chapter 16

      In-Hospital Databases (pages 244–258)

      Brian T. Fisher, Peter K. Lindenauer and Chris Feudtner

  5. Part III: Sources of Data for Pharmacoepidemiologic Studies - Section C: Ad Hoc Studies—Ongoing Systems for Pharmacoepidemiologic Studies

    1. Chapter 19

      Case–Control Surveillance (pages 287–300)

      Lynn Rosenberg, Patricia F. Coogan and Julie R. Palmer

    2. Chapter 21

      Registries (pages 331–346)

      Nancy A. Dreyer and Priscilla Velentgas

  6. Part III: Sources of Data for Pharmacoepidemiologic Studies - Section D: Ad Hoc Studies—De Novo Studies

  7. Part III: Sources of Data for Pharmacoepidemiologic Studies - Section E: Choosing Among the Available Alternatives

  8. Part IV: Selected Special Applications of Pharmacoepidemiology

    1. Chapter 25

      Evaluating and Improving Physician Prescribing (pages 402–422)

      Sumit R. Majumdar, Helene Levens Lipton and Stephen B. Soumerai

    2. Chapter 29

      Risk Management (pages 505–533)

      Gerald J. Dal Pan, Stella Blackburn and Claudia Karwoski

  9. Part V: Selected Special Methodologic Issues in Pharmacoepidemiology

    1. Chapter 34

      Molecular Pharmacoepidemiology (pages 601–622)

      Stephen E. Kimmel, Hubert G. Leufkens and Timothy R. Rebbeck

    2. Chapter 35

      Bioethical Issues in Pharmacoepidemiologic Research (pages 623–639)

      Antoine C. El Khoury, Jason Karlawish, Elizabeth Andrews and Arthur Caplan

  10. Part VI: Conclusion

    1. You have free access to this content
    1. You have free access to this content
    1. You have free access to this content

SEARCH